Opioid analgesic combination

30 marketed 7 in Phase 3

This page covers all Opioid analgesic combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Opioid receptors (mu, delta, kappa); COX inhibition (acetaminophen), Mu opioid receptor (oxycodone); COX enzymes (paracetamol), Mu opioid receptor (codeine); COX enzymes (acetaminophen).

Targets

Opioid receptors (mu, delta, kappa); COX inhibition (acetaminophen) · Mu opioid receptor (oxycodone); COX enzymes (paracetamol) · Mu opioid receptor (codeine); COX enzymes (acetaminophen) · Mu opioid receptor (hydrocodone component); prostaglandin synthesis inhibition (acetaminophen component) · Mu opioid receptor (hydrocodone); COX inhibitor (acetaminophen) · Opioid receptors (mu, kappa, delta) · Mu-opioid receptor (morphine); H1 histamine receptor (promethazine) · Mu opioid receptor (codeine); cyclooxygenase enzymes (acetaminophen) · Mu-opioid receptor; norepinephrine and serotonin transporters; COX enzymes · Mu opioid receptor; norepinephrine transporter; serotonin transporter; cyclooxygenase

Marketed (30)

Phase 3 pipeline (7)